To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04091126
Title Bortezomib, Lenalidomide and Dexamethasone (VRd) With Belantamab Mafodotin Versus VRd Alone in Transplant Ineligible Multiple Myeloma
Acronym DREAMM 9
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | ITA | GBR | FRA | ESP | DEU | CAN | AUS

Facility Status City State Zip Country Details
GSK Investigational Site Westwood Kansas 66205 United States Details
GSK Investigational Site Charlotte North Carolina 28204 United States Details
GSK Investigational Site Madison Wisconsin 53792 United States Details
GSK Investigational Site Newcastle New South Wales 2298 Australia Details
GSK Investigational Site Clayton Victoria 3168 Australia Details
GSK Investigational Site Fitzroy Victoria 3065 Australia Details
GSK Investigational Site Edmonton Alberta T6G 1Z2 Canada Details
GSK Investigational Site London Ontario N6A 5W9 Canada Details
GSK Investigational Site Poitiers 86021 France Details
GSK Investigational Site Dresden 01307 Germany Details
GSK Investigational Site Hamburg 20246 Germany Details
GSK Investigational Site Schwerin 19049 Germany Details
GSK Investigational Site Tuebingen 72076 Germany Details
GSK Investigational Site Bologna 40138 Italy Details
GSK Investigational Site Meldola FC 47014 Italy Details
GSK Investigational Site Seoul 03080 Korea, Republic of Details
GSK Investigational Site Seoul 03722 Korea, Republic of Details
GSK Investigational Site Seoul 137-701 Korea, Republic of Details
GSK Investigational Site Lublin 20-081 Poland Details
GSK Investigational Site Poznan 61-848 Poland Details
GSK Investigational Site Badalona 08916 Spain Details
GSK Investigational Site Barcelona 08036 Spain Details
GSK Investigational Site Madrid 28027 Spain Details
GSK Investigational Site Malaga 29010 Spain Details
GSK Investigational Site PamplonaNavarra 31008 Spain Details
GSK Investigational Site Pozuelo De AlarcOn Madr 28223 Spain Details
GSK Investigational Site Santander 39008 Spain Details
GSK Investigational Site Leicester LE1 5WW United Kingdom Details
GSK Investigational Site Oxford OX3 7LE United Kingdom Details
GSK Investigational Site Southampton SO16 6YD United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field